Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Mar;7(1):15-23.
doi: 10.1007/BF00918004.

Characterization of a high-affinity receptor for phorbol esters in rat alveolar macrophages

Characterization of a high-affinity receptor for phorbol esters in rat alveolar macrophages

J Chang. Inflammation. 1983 Mar.

Abstract

Macrophages display varied responses to the tumor promoter, TPA. In this study, a high-affinity receptor for phorbol ester is characterized in a viable alveolar macrophage population. The binding assay is performed using tritiated PDBu and specific binding is demonstrated to be temperature-sensitive. At 37 degrees C, the level of bound ligand reaches maximal binding within 2-5 min but rapidly decays to within 30% of the original specific binding. Equilibrium, however, can be established when the assay is carried out at 4 degrees C. The data indicate that at this temperature maximal binding is reached within 2 h and remains constant thereafter. Scatchard analysis shows that the receptor has an apparent Kd of 21 nM and each macrophage possesses 2 X 10(5) binding sites. Active phorbol derivatives such as TPA and PDBu compete with the labeled ligand for the receptor, whereas the inactive phorbol alcohol does not modulate the specific binding. Mezerein, a related diterpene which has been shown to share some of the properties of phorbol esters, also competes for the binding site. The high-affinity receptor is not affected by zymosan or EIgG phagocytosis. Inflammatory mediators such as prostaglandins E2 and F2 alpha and platelet-activating factor do not compete for the receptor.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1981 Jul 1;154(1):101-11 - PubMed
    1. Cancer Lett. 1980 May;9(3):229-36 - PubMed
    1. Biochim Biophys Acta. 1980 Dec 15;633(3):410-21 - PubMed
    1. Cancer Res. 1980 Apr;40(4):1028-35 - PubMed
    1. J Cell Biol. 1980 Aug;86(2):634-40 - PubMed

LinkOut - more resources